Article
Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.
Oncology - 1 Jan 2020
Dimberg Jan, Andersson Roland E, Haglund Sofie
Abstract excerpt
BACKGROUND: Identification of high-risk stage II colorectal cancer (CRC) patients, potential candidates for adjuvant chemotherapy, is challenging. Current clinical guidelines rely mainly on histopathological markers with relatively weak prognostic value. This motivates further search for prognostic markers. METHODS: This explorative study aimed to identify potential candidate gene mutations to facilitate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
